Jump to content

Manuel Elkin Patarroyo

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Diannaa (talk | contribs) at 20:29, 23 July 2016 (remove copyright content copied from http://pressenza.com/npermalink/doctor-manuel-elkin-patarroyox-fights-malariax-preventing-millions-from-being-ravaged-by-the-disease). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Template:Spanish name

Manuel Elkin Patarroyo
Manuel Elkin Patarroyo is on the right
Born
Manuel Elkin Patarroyo Murillo

(1946-11-03) November 3, 1946 (age 78)
EducationNational University of Colombia (MD)
Rockefeller University (Ph.D)
Known forMalaria license
Medical career
ProfessionDoctor
InstitutionsHospital San Juan de Dios, Bogota, National University of Colombia
Sub-specialtiesPathologist
ResearchImmunology
AwardsPrince of Asturias Awards (1994) Robert Koch Prize (1994)

Manuel Elkin Patarroyo (born November 3, 1946)[1] is a Colombian Professor of Pathology and Immunology who made the world's first attempt to create a synthetic vaccine against a parasite called the protozoa Plasmodium falciparum that causes severe malaria,[2] a disease transmitted by mosquitoes that affects millions of people and is one of the leading causes of death (~1.5 million people per year) in tropical and subtropical regions, including parts of the Americas, Asia, and Africa.

The vaccine candidate, first developed in 1987 in Colombia, was evaluated in clinical trials carried out by the WHO in Gambia, Tanzania and Thailand, and had mixed results.[3] In 2009, a comprehensive Cochrane review assessed the SPf66 as being not efficacious in Africa and Asia, and as having a low but statistically significant efficacy of 28% in South America.[4] Today, after more than 33 years of research, there is still however no licensed malaria vaccine. Researchers and vaccine developers have been working on many approaches to bring forward the availability of a malaria vaccine."[5] More research and clinical trials are required for a universal vaccine to be implemented.

References

  1. ^ Fundación Príncipe de Asturias. Manuel Elkin Patarroyo (Spanish). Premiados, Investigación Científica y Técnica, 1994.
  2. ^ Holloway, M. (1996) Profile: Manuel Elkin Patarroyo – The Man Who Would Conquer Malaria, Scientific American 275(6), 52-56.
  3. ^ - Susan Aldridge, Magic Molecules: How Drugs Work (Cambridge University Press, 1998), p. 89
  4. ^ - Graves, P. M. and Gelband, H. (2009) Vaccines for preventing malaria (SPf66) (Review), The Cochrane Library 2009, (2), pp.1-38.
  5. ^ - WHO (2010) Tables of Malaria Vaccine Projects Globally (Updated December 2010), Initiative for Vaccine Research.